巴基斯坦人口中胃潰瘍出血的危險因素和結果:單中心觀察研究
Nazish Butt1, Muhammad Tayyab Usmani2, Nimrah Mehak1
1Department of Gastroenterology, Jinnah Postgraduate Medical Centre, Karachi 75505, Sindh, Pakistan.
概括
巴基斯坦的胃潰瘍出血與抗血小板使用和再出血的高死亡率有關. 替代药物增加了再次出血的风险,突出了管理这种常见胃肠道问题的关键因素.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 胃潰瘍疾病 (PUD) 是全球健康面臨的重大挑戰,儘管治療方面取得了進展,但患病率仍持續.
- 非类固醇抗炎药物 (NSAID) 的使用和Helicobacter pylori感染是导致PUD的关键因素,特别是在某些地区.
研究的目的:
- 对风险因素和与胃潰瘍疾病相关的上部胃肠道 (GI) 出血相关的结果进行全面分析.
- 为了调查这些因素,特别是在巴基斯坦人口中.
主要方法:
- 一项回顾性队列研究,涉及142名被诊断患有胃出血的患者.
- 数据收集包括人口统计,症状,住院时间,死亡率,再出血事件和通过上肠道内镜进行Forrest分类.
主要成果:
- 研究人口的平均年龄为53岁,其中68.3%是男性. 常见的症状包括血 (82.4%) 和上胃疼痛 (75.4%).
- 一周后的死亡率为10.6%,一个月后为14.8%. 再次出血发生在14.1%的24小时内,18.3%的7天内.
- 抗血小板药物的使用与死亡率增加相关,而替代药物与更高的再出血率有关. 使用NSAID与福雷斯特III类有关. 重新出血强烈预测死亡率.
结论:
- 抗血小板药物和再出血是PUD相关的上部肠道出血患者早期死亡的重要危险因素.
- 替代药物的使用与这种患者队列中早期再出血的风险增加有关.
相关概念视频
Peptic Ulcer Disease I: Introduction
163
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
163
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
110
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
110
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
570
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
570
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
378
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
378
Peptic Ulcer Disease II: Pathophysiology
379
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
379
Peptic Ulcer Disease V: Surgical Management and Nursing Care
288
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
288


